LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,548 | -3,760 | -8,634 | -62,854 | -53,076 |
| Depreciation Amortization | N/A | N/A | 117 | 1,230 | 1,460 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 78 |
| Other Working Capital | -40 | 200 | -10,320 | 1,025 | 4,277 |
| Other Operating Activity | 9,762 | 169 | 2,306 | 7,420 | 5,677 |
| Operating Cash Flow | $-1,826 | $-3,391 | $-16,531 | $-53,179 | $-41,584 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -18 | -506 | -354 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -51,415 |
| Sale Of Investment | N/A | N/A | 10,000 | 24,665 | 55,750 |
| Purchase Sale Intangibles | N/A | N/A | 855 | -72 | -628 |
| Other Investing Activity | 0 | 0 | 855 | -72 | -628 |
| Investing Cash Flow | $N/A | $N/A | $10,837 | $24,087 | $3,353 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 6,000 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 312 |
| Debt Repayment | N/A | N/A | -376 | -9 | -210 |
| Common Stock Issued | N/A | N/A | N/A | 28,326 | 38,673 |
| Other Financing Activity | 0 | 6,003 | 877 | -151 | 0 |
| Financing Cash Flow | $N/A | $6,003 | $501 | $34,166 | $38,775 |
| Beginning Cash Position | 6,866 | 4,254 | 9,447 | 4,373 | 3,829 |
| End Cash Position | 5,040 | 6,866 | 4,254 | 9,447 | 4,373 |
| Net Cash Flow | $-1,826 | $2,612 | $-5,193 | $5,074 | $544 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,826 | -3,391 | -16,531 | -53,179 | -41,584 |
| Capital Expenditure | N/A | N/A | -18 | -506 | -354 |
| Free Cash Flow | -1,826 | -3,391 | -16,549 | -53,685 | -41,938 |